treatment of cancer by bacterial toxins.the initial experience with toxin therapy forsarcoma and melanoma is reported in3 groups of patients: toxins used as an adjunctto operation in potentially curablepatients, palliative treatment for metastatictumor and toxin therapy supplementedby radiotherapy for localized symptomatictumor masses.  the experience has notbeen encouraging in the first 2 groups.  in 6of 8 patients in the 3rd group there wasmarked objective remission of tumor subsequentto irradiation.  further study isindicated in the use of radiotherapy following'priming' with bacterial toxin injections.